Drug research – Stockmark.IT

AstraZeneca signs a $2bn deal to Chinese firm

Roche data reveals the stomach-churning effects of weight loss drugs

New cancer drugs are expensive but offer hope to patients, but put pressure on budgets

Groundbreaking mRNA Lung Cancer Vaccine Trials Commence Across Seven Nations

AI Revolutionises Drug Discovery Saving Time and Lives for Pharmaceutical Giants

ReNeuron Group Focuses on Exosome Technology Validation and Seeks New Investors

Study finds that weight-loss injections can be associated with a condition that causes blindness

Weight-loss drugs to boom with generic versions

Supplements ‘Ozempic Face’ to counter side effects of rapid weight-loss

Eli Lilly’s Alzheimer’s drug receives support from US advisory panel

Research shows that weight-loss medications can reduce cancer risk by up to a fifth.

Doctors are excited by the melanoma vaccine trial results.

AstraZeneca wants to double its revenues to $80 billion by 2030

Novo Nordisk will test the effects of weight-loss drugs on alcohol consumption and liver disease.

Sir John Bell, tsar of life sciences, believes that London is not the best place to raise funds.

Rare genetic disease treatment becomes the world’s most costly drug at $4.25mn

Novo-Nordisk gives me a boost with a double dose of power.

AstraZeneca purchases rare diseases group in order to boost drug pipeline